There is published support for microneedling in burn scars, and it comes from a combination rather than from needling alone. A prospective study of 15 patients with post-burn hypertrophic scars reported lower Vancouver Scar Scale scores after mechanical microneedling combined with triamcinolone drug delivery the 2023 burn-scar prospective study. That finding is worth raising with a clinician rather than acting on at home.
What did the study find?
The study reported lower Vancouver Scar Scale scores after the combination intervention. Fifteen patients with post-burn hypertrophic scars received mechanical microneedling combined with triamcinolone drug delivery, and the reported change was a within-study observation the 2023 burn-scar prospective study.
The scale used is a standard scar-assessment instrument, which is why the reported improvement is described in scar-score terms rather than in a patient-rated impression. A standard instrument also means the change was judged against a fixed set of criteria rather than by eye alone.
Why is this a combination finding rather than a microneedling result?
Because the intervention delivered two things at once, so the result belongs to the combination. The study used mechanical microneedling together with triamcinolone drug delivery; it did not test needling on its own. Reading the finding as a microneedling-monotherapy result would be reading it as a study that was never run.
That distinction matters for a buyer, because the combination tested here is a clinic protocol rather than a consumer routine. It also means the result cannot be split into a needling contribution and a drug contribution, so any claim about one half alone would be unsupported by this study.
Why does this route you to a clinician?
Because drug-delivery combination protocols are clinical work. The intervention tested here — needling together with a prescription corticosteroid — is delivered in a clinic, and that is where this finding belongs. We sell equipment for consumer courses, and this is not one of them, which is why the useful next step is a professional conversation rather than a cart.
How far should you take this finding?
Take it as a reason to ask about combination delivery for a burn scar, not as a forecast for any individual scar. The cohort is small and the intervention was the combination described, so the finding belongs to the clinic protocol that was tested rather than to burn scars in general.
Traumatic and surgical scars covers the adjacent scar evidence, contraindications covers who should not have the procedure, and reported reactions covers what an early reaction looks like. The question it raises — whether combination delivery suits your scar — is the one worth putting to a professional.
Frequently asked questions
Does microneedling alone treat burn scars?
No. The reported finding is for mechanical microneedling combined with triamcinolone drug delivery. Needling alone was not the intervention tested.
Can I do this protocol at home?
No. The study describes a clinic combination intervention. It belongs in a clinical setting, with the drug component prescribed and delivered by a professional.
Where does this finding apply?
In clinic-delivered combination treatment for post-burn hypertrophic scars. It is not a home routine, and no device claim follows from a single small study.
What should I do with this finding?
Raise it with a qualified clinician as a question about combination delivery. It is a starting point for a conversation.
Take the combination question to a clinician
This is evidence for a clinical conversation rather than a purchase. Read contraindications so you know what to ask about, then traumatic and surgical scars for how the wider scar evidence is framed.